Show simple item record

dc.contributor.authorKerr, Daniel Shikanai
dc.contributor.authorStella, Florindo [UNESP]
dc.contributor.authorRadanovic, Márcia
dc.contributor.authorAprahamian, Ivan
dc.contributor.authorBertollucci, Paulo Henrique Ferreira
dc.contributor.authorForlenza, Orestes Vicente
dc.date.accessioned2018-12-11T17:23:01Z
dc.date.available2018-12-11T17:23:01Z
dc.date.issued2016-02-01
dc.identifierhttp://dx.doi.org/10.1111/bdi.12367
dc.identifier.citationBipolar Disorders, v. 18, n. 1, p. 71-77, 2016.
dc.identifier.issn1399-5618
dc.identifier.issn1398-5647
dc.identifier.urihttp://hdl.handle.net/11449/176904
dc.description.abstractObjectives: Cognitive decline is part of the long-term outcome for many individuals with bipolar disorder (BD). The ε4 allele (APOE*4) of apolipoprotein E (APOE) is a well-established risk factor for dementia in Alzheimer's disease (AD). However, its contribution to the risk of cognitive deterioration in BD has not yet been determined. Our aim was to analyze the APOE genotype association with cognitive status in a sample of older adults with BD and compare this to the association in individuals with AD, individuals with mild cognitive impairment (MCI), and healthy controls. Methods: Participants (n = 475) were allocated to four groups: individuals with BD (n = 77), those with AD (n = 211), those with MCI (n = 43), and healthy controls (n = 144) according to clinical and neuropsychological assessment. APOE was genotyped by real-time polymerase chain reaction. Tukey's honest significant difference test and Pearson's chi-squared test were used to compare diagnostic groups. Results: Subjects with BD were similar to controls with respect to the distribution of the APOE genotype (p = 0.636) and allele frequencies (p = 0.481). Significant differences were found when comparing the AD group to the BD group or to controls (APOE genotype: p < 0.0002; allele frequencies: p < 0.001). APOE*4 was significantly increased in the AD group when compared to the BD group (p = 0.031) and controls (p < 0.0001). The cognitively impaired BD subgroup (Mini-Mental State Examination below the cutoff score and/or neuropsychological assessment compatible with MCI) had a statistically significant higher frequency of APOE*2 compared to the AD group (p = 0.003). Conclusions: APOE*4 is not associated with the diagnosis of BD and does not impact the occurrence of dementia in BD. Given the distinct clinical and biological features of cognitive impairment in BD, we hypothesized that dementia in BD is unrelated to AD pathological mechanisms.en
dc.format.extent71-77
dc.language.isoeng
dc.relation.ispartofBipolar Disorders
dc.sourceScopus
dc.subjectAPOE
dc.subject4
dc.subjectAlzheimer's disease
dc.subjectApolipoprotein E
dc.subjectBipolar disorder
dc.subjectCognitive decline
dc.subjectMild cognitive impairment
dc.titleApolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorderen
dc.typeArtigo
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.description.affiliationLaboratory of Neuroscience (LIM-27) Department and Institute of Psychiatry Faculty of Medicine University of São Paulo (USP)
dc.description.affiliationCenter for Interdisciplinary Research on Applied Neurosciences (NAPNA) University of São Paulo
dc.description.affiliationBiosciences Institute UNESP-Universidade Estadual Paulista
dc.description.affiliationDepartment of Neurology and Neurosurgery Federal University of São Paulo (UNIFESP)
dc.description.affiliationUnespBiosciences Institute UNESP-Universidade Estadual Paulista
dc.identifier.doi10.1111/bdi.12367
dc.rights.accessRightsAcesso restrito
dc.identifier.scopus2-s2.0-84958647258
dc.relation.ispartofsjr2,354
dc.relation.ispartofsjr2,354
Localize o texto completo

Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record